Depressed Natural Cytotoxicity but Normal Natural Killer Cytotoxic Factor (NKCF) Production by Mononuclear Cells Derived from Patients with Hepatocellular Carcinoma

Overview

Journal Cancer Immunol Immunother

Specialties Allergy & Immunology
Oncology
Pharmacology

Date 1987 Jan 1

PMID 2822243

Authors

R H Brookes

M C Kew

A R Rabson

Affiliations

Soon will be listed here.

Abstract

This study investigated the relation between the production of natural killer cytotoxic factors (NKCF) and the phenomenon of natural killing (NK) activity against target K562 cells. Two different models of defective NK cell activity were employed. In the first instance, cytotoxic activity of mononuclear cells (MN) derived from patients with hepatocellular carcinoma was compared to the ability of these cells to produce NKCF. Although direct cytotoxicity was considerably impaired in these patients, the ability of their MN to produce NKCF when stimulated with K562 cells was found to be normal. In the second model, MN treated with the lysosomotropic drug monensin showed considerably reduced direct cytotoxic activity, although they were capable of producing normal amounts of NKCF when activated by K562 cells. These results therefore indicate that there is no correlation between NK activity and corresponding NKCF release, and suggest that NKCF production and activity is independent of direct NK cytotoxic activity.

References

Ortaldo J, Ransom J, Sayers T, Herberman R . Analysis of cytostatic/cytotoxic lymphokines: relationship of natural killer cytotoxic factor to recombinant lymphotoxin, recombinant tumor necrosis factor, and leukoregulin. J Immunol. 1986; 137(9):2857-63. View

Bonavida B, Wright S . Role of natural killer cytotoxic factors in the mechanism of target-cell killing by natural killer cells. J Clin Immunol. 1986; 6(1):1-8. DOI: 10.1007/BF00915358. View

Wright S, Bonavida B . Studies on the mechanism of natural killer cell-mediated cytotoxicity. V. Lack of NK specificity at the level of induction of natural killer cytotoxic factors in cultures of human, murine, or rat effector cells stimulated with mycoplasma-free cell.... J Immunol. 1984; 133(6):3415-23. View

Kaariainen L, Hashimoto K, Saraste J, Virtanen I, Penttinen K . Monensin and FCCP inhibit the intracellular transport of alphavirus membrane glycoproteins. J Cell Biol. 1980; 87(3 Pt 1):783-91. PMC: 2110779. DOI: 10.1083/jcb.87.3.783. View

Graves S, Bramhall J, Bonavida B . Studies on the lethal hit stage of natural killer cell-mediated cytotoxicity. I. Both phorbol ester and ionophore are required for release of natural killer cytotoxic factors (NKCF), suggesting a role for protein kinase C activity. J Immunol. 1986; 137(6):1977-84. View

Farram E, Targan S . Identification of human natural killer soluble cytotoxic factors (NKCF) derived from NK-enriched lymphocyte populations: specificity of generation and killing. J Immunol. 1983; 130(3):1252-6. View

Adams D, Snyderman R . Do macrophages destroy nascent tumors?. J Natl Cancer Inst. 1979; 62(6):1341-5. View

Carpen O, Virtanen I, Saksela E . The cytotoxic activity of human natural killer cells requires an intact secretory apparatus. Cell Immunol. 1981; 58(1):97-106. DOI: 10.1016/0008-8749(81)90152-0. View

Podack E, Dennert G . Assembly of two types of tubules with putative cytolytic function by cloned natural killer cells. Nature. 1983; 302(5907):442-5. DOI: 10.1038/302442a0. View

10.

Roder J, Argov S, Klein M, Petersson C, Kiessling R, Andersson K . Target-effector cell interaction in the natural killer cell system. V. Energy requirements, membrane integrity, and the possible involvement of lysosomal enzymes. Immunology. 1980; 40(1):107-16. PMC: 1458479. View

11.

Tartakoff A, Vassalli P, Detraz M . Comparative studies of intracellular transport of secretory proteins. J Cell Biol. 1978; 79(3):694-707. PMC: 2110276. DOI: 10.1083/jcb.79.3.694. View

12.

Hiserodt J, Britvan L, Targan S . Differential effects of various pharmacological agents on the cytolytic reaction mechanism of the human natural killer lymphocyte: further resolution of programming for lysis and KCIL into discrete stages. J Immunol. 1982; 129(5):2266-70. View

13.

Herman J, Kew M, Rabson A . Defective interleukin-1 production by natural killer cells of patients with cancer. Cancer Immunol Immunother. 1985; 19(2):148-53. PMC: 11039131. DOI: 10.1007/BF00199724. View

14.

Peters P, Ortaldo J, Shalaby M, Svedersky L, Nedwin G, Bringman T . Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes. J Immunol. 1986; 137(8):2592-8. View

15.

Basu S, Goldstein J, Anderson R, Brown M . Monensin interrupts the recycling of low density lipoprotein receptors in human fibroblasts. Cell. 1981; 24(2):493-502. DOI: 10.1016/0092-8674(81)90340-8. View

16.

Kasahara T, Djeu J, Dougherty S, Oppenheim J . Capacity of human large granular lymphocytes (LGL) to produce multiple lymphokines: interleukin 2, interferon, and colony stimulating factor. J Immunol. 1983; 131(5):2379-85. View

17.

Scala G, Allavena P, Djeu J, Kasahara T, Ortaldo J, Herberman R . Human large granular lymphocytes are potent producers of interleukin-1. Nature. 1984; 309(5963):56-9. DOI: 10.1038/309056a0. View

18.

Herman J, Dinarello C, Kew M, Rabson A . The role of interleukin 1 (IL 1) in tumor-NK cell interactions: correction of defective NK cell activity in cancer patients by treating target cells with IL 1. J Immunol. 1985; 135(4):2882-6. View

19.

Wright S, Bonavida B . Selective lysis of NK-sensitive target cells by a soluble mediator released from murine spleen cells and human peripheral blood lymphocytes. J Immunol. 1981; 126(4):1516-21. View

20.

Young J, Hengartner H, Podack E, COHN Z . Purification and characterization of a cytolytic pore-forming protein from granules of cloned lymphocytes with natural killer activity. Cell. 1986; 44(6):849-59. DOI: 10.1016/0092-8674(86)90007-3. View